Ovarian cancer prevention: a simple Add-On during gallbladder surgery?

NCT ID NCT07625137

Not yet recruiting Prevention Sponsor: University of British Columbia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether removing the fallopian tubes at the same time as gallbladder surgery is safe and practical. Ovarian cancer often starts in the fallopian tubes, so removing them may prevent it. The trial will enroll 240 women aged 35 and older to see if the extra procedure is feasible and doesn't cause complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bilateral salpingectomy (removal of both fallopian tubes)
What this could lead to: If successful, this could offer a simple way to prevent ovarian cancer during common gallbladder surgery, reducing cancer risk without extra major procedures.
What could go wrong: This is an early feasibility study with only 240 participants. It may show the procedure is not safe or practical, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC CHOLECYSTECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LAPAROSCOPIC CHOLECYSTECTOMY SALPINGECTOMY

Contacts and locations

Locations

Hamilton Health Sciences Center

Hamilton, Ontario, Canada
Langley Memorial Hospital

Langley, British Columbia, Canada
Vancouver General Hospital (VGH)

Vancouver, British Columbia, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.